As of July 2026, 64 paid clinical trials are recruiting in Arlington, Texas. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Arlington offers studies at sites including University of Texas at Arlington for conditions such as Atopic Dermatitis, Advanced Non-Small Cell Lung Cancer, Aging, Benign Prostatic Hyperplasia. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Researchers run research studies in Arlington, TX at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| University of Texas at Arlington | Quality of Life, Aging, Alcohol Abstinence | 6 |
| Texas Clinical Research Institute, LLC | Liver Cirrhosis, Liver Fibrosis, Metabolic Dysfunction Associated Steatohepatitis | 4 |
| UPNT Research Institute | Bladder (Urothelial, Transitional Cell) Cancer, Incontinence, Urinary, NMIBC | 4 |
| Texas Oncology - DFW | Advanced Non-Small Cell Lung Cancer, Breast Cancer, Breast Neoplasms | 3 |
| Arlington Research Center, Inc | Alopecia Areata, Atopic Dermatitis | 3 |
| Arlington Center for Dermatology | Chronic Spontaneous Urticaria (CSU), Plaque Psoriasis | 2 |
| Arlington Research Center | Dermatitis Atopic | 2 |
| GSK Investigational Site | Liver Diseases, Alcoholic, Non-alcoholic Fatty Liver Disease | 2 |
| The Center for Cancer and Blood Disorders | Metastatic Castration-resistant Prostate Cancer, Non-Small Cell Lung Cancer Metastatic, Non-Small Cell Lung Carcinoma | 2 |
| UPNT Research Institute, LLC | High-Risk Non-Muscle-Invasive Bladder Cancer, Upper Urinary Tract Urothelial Carcinoma, Urothelial Carcinoma | 2 |
| University of Texas Arlington | Aging, Peripheral Artery Disease (PAD) | 2 |
| Urology Partners of North Texas | Erectile Dysfunction (ED), Non-muscle Invasive Bladder Cancer | 2 |
| Clinical Trial Site | High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension | 1 |
| Adverum Clinical | Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD | 1 |
| Akero Clinical Study Site | MASH - Metabolic Dysfunction-Associated Steatohepatitis, NASH - Nonalcoholic Steatohepatitis | 1 |
| Arlington | Endometriosis, Uterine Fibroids | 1 |
| Arlington Nephrology | Autosomal Dominant Polycystic Kidney Disease | 1 |
| Arlington Nephrology, PLLC. | Diabetic Kidney Disease (DKD) | 1 |
| Arlington Research Center, Inc. | Hidradenitis Suppurativa | 1 |
| Artiva Investigational | IIM, Idiopathic Inflammatory Myopathies (IIMs), Myositis | 1 |
| Enveda Investigative Site | Atopic Dermatitis (AD) | 1 |
| Galderma Investigational | Systemic Sclerosis | 1 |
| Hs0006 50201 | Hidradenitis Suppurativa | 1 |
| Investigative Site | CLE, Cutaneous Lupus Erythematosus (CLE), SLE | 1 |
| Investigator | Focal Segmental Glomerulosclerosis | 1 |
Recruiting trials in Arlington grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
There are approximately 64 recruiting clinical trials in Arlington, Texas listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in Arlington compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in Arlington include Atopic Dermatitis (3), Advanced Non-Small Cell Lung Cancer (2), Aging (2), Benign Prostatic Hyperplasia (2), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Arlington on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in Arlington include University of Texas at Arlington, Texas Clinical Research Institute, LLC, UPNT Research Institute, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in Arlington are Cancer & tumors (14), Cardiovascular (4), Eye & vision (3). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.